Showing results (531-540 of 715) with videos related to
Sort By:
Pageof 72
JCI Insight|March 14, 2024
OGDH and Bcl-xL loss causes synthetic lethality in glioblastomaTrang Tt Nguyen, Consuelo Torrini, Enyuan Shang, et al.Annals of the Rheumatic Diseases|May 24, 2007
BILAG-2004 index captures systemic lupus erythematosus disease activity better than SLEDAI-2000C-S Yee, D A Isenberg, A Prabu, et al.Arthritis and Rheumatism|December 1, 2007
British Isles Lupus Assessment Group 2004 index is valid for assessment of disease activity in systemic lupus erythematosusChee-Seng Yee, Vernon Farewell, David A Isenberg, et al.Neurosurgery|August 4, 2019
Frameless Stereotactic Radiosurgery on the Gamma Knife Icon: Early Experience From 100 PatientsHoria Vulpe, Akshay V Save, Yuanguang Xu, et al.Rheumatology (Oxford, England)|February 26, 2010
Numerical scoring for the BILAG-2004 indexChee-Seng Yee, Lynne Cresswell, Vernon Farewell, et al.Neuro-Oncology|July 2, 2021
BOLD asynchrony elucidates tumor burden in IDH-mutated gliomasPetros D Petridis, Craig I Horenstein, Brianna Pereira, et al.Rheumatology (Oxford, England)|January 20, 2011
The use of Systemic Lupus Erythematosus Disease Activity Index-2000 to define active disease and minimal clinically meaningful change based on data from a large cohort of systemic lupus erythematosus patientsChee-Seng Yee, Vernon T Farewell, David A Isenberg, et al.Annals of the Rheumatic Diseases|July 21, 2010
Variants in linkage disequilibrium with the late cornified envelope gene cluster deletion are associated with susceptibility to psoriatic arthritisJohn Bowes, Edward Flynn, Pauline Ho, et al.Neuro-Oncology|December 6, 2013
MDA-9/syntenin is a key regulator of glioma pathogenesisTimothy P Kegelman, Swadesh K Das, Bin Hu, et al.Lupus Science & Medicine|May 22, 2024
Disease-modifying therapies in systemic lupus erythematosus for extrarenal manifestationsAnca D Askanase, Richard A Furie, Maria Dall'Era, et al.Pageof 72